The global antibody drug conjugate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The increasing geriatric population, rising prevalence of various types of cancer , and increased government investments in pharmaceutical research and development activities for more advanced cancer drugs and therapeutics are the key factors driving the global […]
